Improving the Therapeutic benefit of immunotherapy in Neuroblastoma by combining autophagy inhibitor and anti-PD-i

Project Details

AcronymCombiN (Elisabetta Bartolini)
StatusActive
Effective start/end date1/02/2331/01/27

Funding

  • Stiftelsen Cancera: €292,996.00